Corridome

Immunocore

T cell receptor biotechnology 2 current owners

Read from its owners' websites on Oct 26, 2026

  1. Immunocore is a private company in the T cell receptor biotechnology sector.

    Website
  2. Pharmakon Advisorsfirm and Avego Managementfirm list it as a current portfolio company.

    Website
  3. 2 deals name it. The latest is a financing in Nov 2022.

    Websitelisting
  4. Pharmakon Advisorsfirm also lists ARCHIMED and Esperion Therapeuticscompany and Idorsiacompany.

    Website

Owners

2 owners

FirmStatusSource
Pharmakon Advisors · Investment adviserCurrent · 2022Website
Avego Management · Investment adviserCurrent · 2020Website

Deals

2 deals

DateDealFirmsSource
Nov 2022FinancingPharmakon Advisors (buyer)Websitelisting
Jan 1, 2021InvestmentAvego Management (buyer)Website

Other companies its owners list

first 2 of 10

CompanyOwnerStatusSource
ARCHIMED and Esperion TherapeuticsPharmakon AdvisorsCurrentWebsite
Alveus TherapeuticsAvego ManagementCurrentWebsite

8 more companies

Listed by Pharmakon Advisors and Avego Management.

Sign up free to see the first 5, or become a member to see all 10.

Sign up freeBecome a member